CAS 303997-35-5

8-Chloro-4-phenylsulfanyl-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline

CAS: 303997-35-5

Fórmula: C₁₆H₈ClF₃N₄S

Pureza: 99%

Forma y color: Solid

Peso molecular: 380.7747

Ref: IN-DA01DUAM

R-7050

CAS: 303997-35-5

R-7050

Fórmula: C₁₆H₈ClF₃N₄S

Pureza: ≥98%

Peso molecular: 380.77

Ref: 54-BUP10041

R-7050

CAS: 303997-35-5

R-7050 (TNF-α Antagonist III), a tumor necrosis factor receptor (TNFR) antagonist, exhibits heightened selectivity for TNFα.

Fórmula: C₁₆H₈ClF₃N₄S

Pureza: 98.64% - 99.8%

Forma y color: White Solid

Peso molecular: 380.77

Ref: TM-T4637

R-7050

CAS: 303997-35-5

8-Chloro-4-(phenylthio)-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline

Fórmula: C₁₆H₈ClF₃N₄S

Pureza: 99%

Peso molecular: 380.77

Ref: IN-DG00759591

8-chloro-4-phenylsulfanyl-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline

CAS: 303997-35-5

Pureza: 99%

Peso molecular: 380.769989

Ref: 10-F864145

TNF-± Antagonist III, R-7050

CAS: 303997-35-5

TNF-± Antagonist III is a drug that is used to inhibit the production of TNF-α. It has been shown to regulate transcriptional activity in cells and to inhibit the growth of cancer cells. TNF-± Antagonist III has been observed to decrease the M2 phenotype, which may be due to its ability to activate ATP levels in macrophages. This drug also inhibits kidney fibrosis by reducing pro-inflammatory factors, such as tumor necrosis factor-α (TNF-α) and fatty acids. The drug also has effects on abdominal surgery, as it reduces inflammation following this type of procedure. TNF-± Antagonist III is used in fat tissue and adipose tissue, where it reduces the number of pro-inflammatory factors produced by macrophages.

Fórmula: C₁₆H₈ClF₃N₄S

Pureza: Min. 95%

Peso molecular: 380.77 g/mol

Ref: 3D-DMA99735